Immune responses and protective efficacy of recombinant baculovirus- expressed glycoproteins of equine herpesvirus 1 (EHV-1) gB, gC and gD alone or in combinations in BALB/c mice

Veterinary Microbiology

Volumn 61, Issue 4, 1998, Pages 261-278

  Packiarajah, P ^a   Walker, Catherine ^b   Gilkerson, James ^a   Whalley, J Millar ^b   Love, Daria N ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b MACQUARIE UNIVERSITY   (Australia)

Author keywords

Baculovirus; Equine herpesvirus 1; Immune responses mouse; Mouse model; Pathogenesis viruses; Recombinant glycoproteins

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACULOVIRUS; CELL PROTECTION; CONTROLLED STUDY; GENE DELETION; IMMUNE RESPONSE; IMMUNOCYTOCHEMISTRY; MONONUCLEAR CELL; MOUSE; NONHUMAN; PATHOGENESIS; TARGET CELL; VACCINATION; VIRUS EXPRESSION;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY FORMATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, EQUID; HORSE DISEASES; HORSES; LUNG; MICE; MICE, INBRED BALB C; RECOMBINANT PROTEINS; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 17144446837     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1135(98)00189-8     Document Type: Article

References (65)

1. Allen G.P., Bryans J.T. Molecular epizootiology, pathogenesis and prophylaxis of equine herpesvirus 1 infections. Prog. Vet. Microbiol. Immunol. 2:1986;78-144.
2. Allen G.P., Yeargan M.R. Use of λg11 and monoclonal antibodies to map the genes for the six major glycoproteins of equine herpesvirus 1. J. Virol. 61:1987;2454-2461.
3. Allen, G.P., Coogle, L.D., Ostlund, E.N., Yeargan, M.R., 1991. Molecular dissection of two major equine herpesvirus-1 glycoprotein antigens (gB and gC) that elicit humoral immune responses in the horses. Proc. 6th Int. Conf. Equine Infectious Dis. IV, pp. 181-193.
4. Awan A.R., Chong Y.C., Field H.J. The pathogenesis of equine herpesvirus type 1 in the mouse: a new model for studying host responses to the infection. J. Gen. Virol. 71:1990;1131-1140.
5. Babiuk L.A., van Drunen Littel-van den Hurk S., Tikoo A. Immunology of bovine herpesvirus 1 infection. Vet. Microbiol. 35:1996;311-342.
6. Bourne N., Milligan G.N., Schleiss M.R., Bernstein D.I., Stanberry L.R. DNA immunization confers protective immunity on mice challenged intravaginally with herpes simplex virus type 2. Vaccine. 14:1996;1230-1234.
7. Boursnell M.E.G., Entwistle C., Blakeley D., Roberts C., Duncan I.A., Chisholm S.E., Martin G.M., Jennings R., Challanain D.N., Sobek I., Inglis S.E., McLean C.S. A genetically inactivated herpes simplex virus type 2 (HSV-2) vaccine provides effective protection against primary and recurrent HSV-2 disease. J. Infect. Dis. 175:1997;16-25.
8. Bürki F., Rossmanith W., Nowotny N., Pallan C., Möstl K., Lussy H. Viremia and abortions are not prevented by two commercial equine herpesvirus-1 vaccines after experimental challenge of horses. Vet. Q. 12:1990;80-86.
9. Burrows R. Some observations on the viral aetiology of upper respiratory disease of British horses. 1965-1967. Bull. Off. Int. Epiz. 70:1968;181-196.
10. Burrows R., Goodridge D., Denyer M.S. Trials of an inactivated equid herpesvirus 1 vaccine: Challenge with a subtype 1 virus. Vet. Rec. 114:1984;369-374.
11. Cai W., Gu B., Person S. Role of glycoprotein B of herpes simplex virus type 1 in viral entry and cell fusion. J. Virol. 62:1988;2596-2604.
12. Cook, R.F., O'Neill, T., Strachan, E., Sundquist, B., Mumford, J.A., 1990. Protection against lethal equine herpesvirus type 1 (subtype 1) infection in hamsters by immune stimulating complexes (ISCOMS) containing the major viral glycoproteins. Vaccine 8, pp. 491-496.
13. Cox G.J.M., Zamb T.J., Babiuk L.A. Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA. J. Virol. 67:1993;5664-5667.
14. Crabb B.S., Studdert M.J. Equine herpesviruses 4 (equine rhinopneumonitis virus) and 1 (equine abortion virus). Adv. Virus. Res. 45:1995;153-190.
15. Csellner H., Whalley J.M., Love D.N. Equine herpesvirus 1 HVS25A isolated from an aborted foetus produces disease in Balb/c mice. Aust. Vet. J. 62:1995;68-69.
16. Denis M., Hanon E., Rijsewijk F.A., Kaashoek M.J., van Oirschot J.T., Thiry E., Pastoret P.P. The role of glycoproteins gC, gE, gI and gG in induction of cell-mediated immune responses to bovine herpesvirus 1. Vet. Microbiol. 53:1996;121-132.
17. Doll E.R., Bryans J.T. Epizootiology of equine viral rhinopneumonitis. J. Am. Vet. Med. Assoc. 142:1963;31-37.
18. Eis-Hübinger A.M., Mohr K., Schneweis K.E. Different mechanisms of protection of monoclonal and polyclonal antibodies during the course of herpes simplex virus infection. Intervirology. 32:1991;351-360.
19. Eis-Hübinger A.M., Schmidt D.S., Schneweis K.E. Anti-glycoprotein B monoclonal antibody protects T cell-depleted mice against herpes simplex virus infection by inhibition of virus replication at the inoculated mucous membranes. J. Gen. Virol. 74:1993;379-385.
20. Ghiasi, H., Kaiwar, R., Nesburn, A.B., Wechsler, S.L., 1992a. Expression of herpes simplex virus type 1 glycoprotein B in insect cells. Initial analysis of its biochemical and immunological properties. Virus Res. 22, 25-39.
21. Ghiasi, H., Kaiwar, R., Nesburn, A.B., Wechsler, S.L., 1992b. Baculovirus expressed herpes simplex virus type 1 glycoprotein C protects mice from lethal HSV-1 infection. Antiviral Res. 18, 291-302.
22. Ghiasi H., Kaiwar R., Nesburn A.B., Slanina S., Wechsler S.L. Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gI): Comparative protection against lethal challenge in mice. J. Virol. 68:1994;2118-2126.
23. Gilkerson J., Love D.N., Whalley J.M. A review of equine herpesvirus vaccines: from the traditional to the experimental. Aust. Equine Vet. 15:1997;27-32.
24. Guo P., Goebel S., Davis S., Perkus M.E., Languet B., Desmettre P., Allen G., Paoletti E. Expression in recombinant vaccinia virus of the equine herpesvirus 1 gene encoding glycoprotein gp13 and protection of immunized animals. J. Virol. 63:1989;4189-4198.
25. Guo P., Goebel S., Perkus M.E., Taylor J., Norton E., Allen G., Languet B., Desmettre P., Paoletti E. Coexpression by vaccinia virus recombinants of equine herpesvirus 1 glycoproteins gp 13 and gp 14 results in potentiated immunity. J. Virol. 64:1990;2399-2406.
26. Hannant D., Jessett D.M., O'Neill T., Dolby C.A., Cook R.F. Responses of ponies to equid herpesvirus 1 ISCOM vaccination and challenge with virus of the homologous strain. Res. Vet. Sci. 54:1993;299-305.
27. Hemsley S., Canfield P.J., Husband A.J. Immunohistological staining of lymphoid tissue in four Australian marsupial species using species cross-reactive antibodies. Immunol. Cell Biol. 73:1995;321-325.
28. Herold B.C., Wudunn D., Soltys N., Spear P.G. Glycoprotein gC of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J. Virol. 65:1991;1090-1098.
29. Inumaru S., Yamada S. Characterization of pseudorabies virus neutralization antigen glycoprotein gIII produced in insect cells by a baculovirus expression vector. Virus Res. 21:1991;123-139.
30. Kaashoek M.J., van Oirschot J.T. Early immunity induced by a live gE-negative bovine herpesvirus 1 marker vaccine. Vet. Microbiol. 53:1996;191-197.
31. Kukreja, A., Whalley, J.M., Field, H.J., 1997. Analysis of protective immune responses to the co-expressed glycoprotein H and glycoprotein L of equine herpesvirus 1 in a mouse model. 22nd International Herpesvirus Workshop, San Diego, USA, p. 559.
32. Landolfi V., Zarley C.D., Abramovitz A.S., Figueroa N., Wu S.L., Blasiak M., Ishizaka S.T., Mishkin E.M. Baculovirus-expressed herpes simplex virus type 2 glycoprotein D is immunogenic and protective against lethal HSV challenge. Vaccine. 11:1993;407-414.
33. Langenberg A.G.M., Burke R.L., Adair S.F., Sekulovich O., Tigges M., Dekker C.L., Corey L. A recombinant glycoprotein vaccine for herpes simplex type 2 - safety and efficacy. Ann. Int. Med. 122:1995;889-898.
34. Love D.N., Bell C.W., Whalley J.M. Characterization of the glycoprotein D gene products of equine herpesvirus 1 using a prokaryotic cell expression vector. Vet. Microbiol. 30:1992;387-394.
35. Love D.N., Bell C.W., Pye D., Edwards S., Hayden M., Lawrence G.L., Boyle D., Pye T., Whalley J.M. Expression of equine herpesvirus 1 glycoprotein D by using a recombinant baculovirus. J. Virol. 67:1993;6820-6823.
36. Martin S., Rouse B.T. The mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: clearance of local infection. J. Immunol. 138:1987;3431-3437.
37. McGowan E.M., Hayden M.B., Edwards S.J., Pye D., Love D.N., Whalley J.M. Expression and characterization of equine herpesvirus 1 glycoprotein H using a recombinant baculovirus. Arch. Virol. 137:1994;389-395.
38. Mettenleiter T.C., Klupp B.G., Weiland F., Visser N. Characterization of a quadruple glycoprotein-induced pseudorabies virus mutant for use as a biologically safe live virus vaccine. J. Gen. Virol. 75:1994;1723-1733.
39. Neubauer, A., Braun, B., Brandmuller, C., Kaaden, O.R., Osterrieder N., 1997a. Analysis of the contributions of the equine herpesvirus 1 glycoprotein gB homolog to virus entry and direct cell-to-cell spread. Virology 227, 281-294.
40. Neubauer, A., Kaaden, O.R., Osterrieder, N., 1997b. Glycoproteins B and M are required for pathogenicity of equine herpesvirus 1 in a murine model. 22nd International Herpesvirus Workshop, San Diego, USA, p. 450.
41. Norrild, B., 1985. Humoral responses to herpes simplex infections. In: Roizman, B., Lopez, C. (Eds.), The Herpesviruses. vol. 2. Plenum Press, New York, pp. 69-86.
42. O'Callaghan, D.J., Gentry, G.A., Randall, C.C., 1985. The equine herpesviruses. In: Roizman, B., Lopez, C. (Eds.), The Herpesviruses, vol. 2. Plenum Press, New York, pp. 215-318.
43. Osterrieder N., Wagner R., Pfeffer M., Kaaden O.R. Expression of equine herpesvirus type 1 glycoprotein gp14 in Escherichia coli and in insect cells: a comparative study on protein processing and humoral immune response. J. Gen. Virol. 75:1994;2041-2046.
44. Osterrieder N., Wagner R., Brandmueller C., Schmidt P., Wolf H., Kaaden O.R. Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB). Virology. 208:1995;500-510.
45. Osterrieder N., Neubauer A., Brandmuller C., Kaaden O.R. Efficacy of recombinant EHV-1 vaccines. Tieraerztl. Umsch. 51:1996;683-687.
46. Reed L.J., Muench H. A simple method of estimating 50 percent end points. Am. J. Hyg. 37:1938;493.
47. Sabine M., Robertson G.R., Whalley J.M. Differentiation of sub-types of equine herpesvirus 1 by restriction endonuclease analysis. Aust. Vet. J. 57:1981;148-149.
48. Spear, P.G., 1985. Glycoproteins specified by herpes simplex virus. In: Roizman, B., Lopez, C. (Eds.), The Herpesviruses. vol. 2. Plenum Press, New York, pp. 315-356.
49. Staats H.A., Oakes J.E., Lausch R.N. Anti-glycoprotein D monoclonal antibody protects against herpes simplex type 1-induced diseases in mice functionally depleted of selected T-cell subsets or Asialo GM1 cells. J. Virol. 65:1991;6008-6014.
50. Stokes A., Wardley R.C. ADCC and complement-dependent lysis as immune mechanisms against EHV-1 infection in the horse. Res. Vet. Sci. 44:1988;295-302.
51. Stokes A., Allen G.P., Pullen L.A., Murray P.K. A hamster model of equine herpesvirus type 1 (EHV-1) infection: Passive protection by monoclonal antibodies to EHV-1 glycoproteins 13, 14 and 17/18. J. Gen. Virol. 70:1989;1173-1183.
52. K) mice against virus challenge. Virus Res. 44, 1996, 97-109.
53. Stokes, A., Alber, D.C., Greensill, J., Amellal, B., Carvalho, R., Taylor, L.A., Doel, T.R., Killington, R.A., Halliburton, I.W., Meredith, D.M., 1996b. The expression of the proteins of equine herpesvirus 1 which share homology with herpes simplex virus 1 glycoproteins H and L. Virus Res. 40, 91-107.
54. Sullivan D.C., Allen G.P., O'Callaghan D.J. Synthesis and processing of equine herpesvirus type 1 glycoprotein 14. Virology. 173:1989;638-646.
55. Tewari D., Nair S.V., De-Ungria M.C., Lawrence G.L., Hayden M., Love D.N., Field H.J., Whalley J.M. Immunization with glycoprotein C of equine herpesvirus-1 is associated with accelerated virus clearance in a murine model. Arch. Virol. 140:1995;789-797.
56. Tewari D., Whalley J.M., Love D.N., Field H.J. Characterization of immune responses to baculovirus-expressed equine herpesvirus type 1 glycoproteins D and H in a murine model. J. Gen. Virol. 75:1994;1735-1741.
57. Thomson G.R., Mumford J.A., Campbell T., Griffiths L., Clapham P. Serological detection of equid herpesvirus 1 infection of the respiratory tract. Equine Vet. J. 8:1976;58-65.
58. van Drunen Littel-van den Hurk S.V., Parker M.D., Manic B., van den Hurk J.V., Harlent R., Babiuk L.A., Zamb T.J. Protection of Cattle from BVH-1 infection by immunization with recombinant glycoprotein IV. Vaccine. 11:1993;25-35.
59. Wellington J.E., Love D.N., Whalley J.M. Evidence for involvement of equine herpesvirus 1 glycoprotein B in cell-cell fusion. Arch. Virol. 141:1996;167-175.
60. Whalley J.M., Love D.N., Tewari D., Field H.J. Characteristics of equine herpesvirus 1 glycoproteins expressed in insect cells. Vet. Microbiol. 46:1995;193-201.
61. Whalley J.M., Robertson G.R., Davison A.J. Analysis of the genome of equine herpesvirus type 1: Arrangement of cleavage sites for restriction endonuclease EcoRI, BalII and BamHI. J. Gen. Virol. 57:1981;307-323.
62. Whalley J.M., Robertson G.R., Scott N.A., Hudson G.C., Bell C.W., Woodworth L.M. Identification and nucleotide sequence of a gene in equine herpesvirus 1 analogous to the herpes simplex virus gene encoding the major envelope glycoprotein gB. J. Gen. Virol. 70:1989;383-394.
63. Whalley, J.M., Ruitenberg, K., Munro, K., Walker, C., Wellington, J., Love, D.N., 1997. Genetic immunisation with equine herpesvirus 1 glycoproteins D and B. 22nd International Herpesvirus Workshop. San Diego, USA, p. 560.
64. Whittaker G.R., Taylor L.A., Elton D.M., Giles L.E., Bonass W.A., Halliburton I.W., Killington R.A., Meredith D.M. Glycoprotein 60 of equine herpesvirus type 1 is a homologue of herpes simplex virus glycoprotein D and plays a major role in penetration of cells. J. Gen. Virol. 73:1992;801-809.
65. Xuan X., Nakamura T., Ihara T., Sato I., Tuchiya K., Nosetto E., Ishihama A., Ueda S. Characterization of pseudorabies virus gII expressed by recombinant baculovirus. Virus Res. 36:1995;151-161.